Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.60
0.05 (9.89%)
At close: Aug 15, 2025, 3:59 PM
0.61
1.65%
After-hours: Aug 15, 2025, 07:57 PM EDT

Rallybio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
9.45M 14.78M 13.9M 25.32M 16.67M 19.3M 24.49M 19.16M 32.56M 39.52M 56.96M 132.42M 60.75M 81.42M 175.33M 186.98M 112.73M 127.74M
Short-Term Investments
36.3M 39.72M 51.61M 49.82M 71.94M 74.87M 85.44M 102.23M 105.28M 110.87M 112.04M 80.71M 86.61M 79.98M n/a n/a n/a n/a
Long-Term Investments
n/a 413K n/a 431K 568K 304K 239K 102K n/a 217K 30K 244K 227K 415K 805K 1.03M 1.36M 328K
Other Long-Term Assets
626K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
4.52M 872K 995K 1.75M 2.82M 768K 4.86M 3.59M 9M 10.89M 1.05M 10.01M 6.93M 6.37M 5.54M 5.41M 5.7M n/a
Total Current Assets
50.27M 57.38M 67.84M 78.23M 91.44M 98.55M 114.79M 132.42M 146.83M 161.28M 179.5M 142.43M 154.3M 167.78M 180.87M 192.39M 118.43M 128.71M
Property-Plant & Equipment
112K 189K 267K 346K 427K 510K 592K 670K 742K 825K 909K 993K 1.08M 1.16M 511K 445K 306K 312K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
738K 602K 267K 777K 995K 814K 831K 772K 742K 1.04M 939K 1.24M 1.31M 1.57M 1.32M 1.47M 1.67M 640K
Total Assets
51M 57.98M 68.11M 79.01M 92.43M 99.36M 115.62M 133.19M 147.58M 162.32M 180.44M 143.67M 155.61M 169.35M 182.19M 193.87M 120.1M 129.35M
Account Payables
119K 400K 278K 583K 1.22M 470K 976K 464K 689K 782K 1.11M 828K 633K 1.06M 603K 2.6M 2.62M 3.01M
Deferred Revenue
636K 848K 848K 1.1M 1.2M n/a n/a n/a n/a n/a n/a n/a -150K n/a n/a n/a n/a n/a
Short-Term Debt
58K n/a n/a n/a 226K n/a 219K 217K 213K 197K n/a 165K 150K 148K n/a n/a n/a n/a
Other Current Liabilities
4.23M 964K 3.1M 6.28M 6.53M 5.51M 4.68M 5.18M 4.7M 4.21M 4.7M 5.96M 3.67M 3.4M 2.99M n/a n/a n/a
Total Current Liabilities
5.04M 3.91M 6.24M 8.19M 12.16M 10.09M 9.26M 9.4M 8.05M 6.8M 10.74M 11.29M 7.28M 5.8M 6.55M 7.34M 7.41M 6.08M
Long-Term Debt
n/a n/a n/a n/a 58K n/a 173K 211K 266K 321K n/a 428K 478K 517K n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a -58K n/a -173K -211K -266K -321K n/a -428K -478K -517K 32K 35K 182.05M 182.05M
Total Long-Term Liabilities
n/a n/a 212K n/a 253K 116K 173K 211K 266K 321K 374K 428K 478K 517K 32K 35K 182.05M 182.05M
Total Liabilities
5.04M 3.91M 6.45M 8.19M 12.41M 10.2M 9.44M 9.61M 8.32M 7.12M 11.12M 11.72M 7.76M 6.32M 6.58M 7.38M 189.46M 188.13M
Total Debt
58K 116K 154K 230K 284K 339K 392K 428K 479K 518K 555K 593K 628K 665K n/a n/a n/a n/a
Common Stock
4K 4K 4K 4K 4K 4K 4K 4K 4K 4K 4K 3K 3K 3K 3K 3K 2.05M 1.51M
Retained Earnings
-312.16M -302.46M -293.02M -281.98M -270.51M -254.27M -235.25M -215M -196.63M -178M -160.68M -144.48M -126.11M -108.53M -94.03M -81.61M -71.42M -60.29M
Comprehensive Income
n/a 47K 68K 169K -71K -71K 15K -208K -272K -61K -214K -434K -371K -122K 0.00 -0.00 1.51M 1.02M
Shareholders Equity
45.96M 54.07M 61.65M 70.82M 80.02M 89.16M 106.18M 123.58M 139.26M 155.2M 169.32M 131.94M 147.85M 163.04M 175.6M 186.49M 112.66M -60.29M
Total Investments
n/a 40.13M 51.61M 50.25M 72.51M 75.18M 85.67M 102.23M 105.28M 111.09M 112.07M 80.95M 86.84M 80.4M 805K 1.03M 1.36M 328K